Laser Assisted Therapies and Immunotherapies for Oncology
Assisted Laser Therapies and Immunotherapies for Oncology
Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.
On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.
The meeting to set up the pilot, monocentric, descriptive, feasibility, safety and tolerance study of the BUBOLight® device "took place on September 14 at the Jeanne de Flandre Maternity Unit of the [...]